Today: 3 April 2026
Subscribe
Browse Category

NASDAQ:NEUP 24 October 2025

Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria Stock Crashes After Social Anxiety Trial Failure — What’s Next?

Neuphoria shares plunged about 67% in after-hours trading Oct. 20 after its lead drug BNC210 failed a Phase 3 trial for social anxiety disorder. The company halted its social anxiety program, began a strategic review, and said it would cut spending. NEUP stock dropped from $15.40 to near $4.05 before rebounding to $6.70 by Oct. 24. Neuphoria reported $14.2 million in cash as of June 30 and maintains a partnership with Merck.
24 October 2025
·

Stock Market Today

  • Hugo Boss Share Price Slides 40% Over Three Years, DCF Model Suggests Undervaluation
    April 3, 2026, 5:13 AM EDT. Hugo Boss (XTRA:BOSS) shares have declined 40.3% over three years, closing at €36.23 recently. Despite mixed performance, the luxury apparel brand returned 11.1% over the past year. Simply Wall St's Discounted Cash Flow (DCF) analysis estimates an intrinsic value of €98.36 per share, indicating the stock trades at a 63.2% discount. The DCF model, which projects future cash flows discounted to present value, suggests the shares are materially undervalued. Investors should weigh these findings against the brand's position and market risks before considering new positions.
Go toTop